Author(s): Margaux Games, Zane Sejdiu*, Erum Ilyas
Body Dysmorphic Disorder (BDD) is a psychiatric disorder characterized by a preoccupation with perceived physical flaws, resulting in significant distress and impairment. The prevalence of BDD in the general population ranges 0.7% to 2.4%, with significantly higher rates observed in dermatological settings (9% to 12%) and cosmetic surgery settings (3%-53%). BDD patients frequently seek dermatological rather than psychiatric help, often undergoing unnecessary cosmetic procedures, increasing physical and psychological risks. Effective diagnosis of BDD in dermatologic settings requires screening tools such as the Body Dysmorphic Disorder Questionnaire-Dermatology Version (BDDQ-DV) and the adolescent version. Treatment typically involves Selective Serotonin Reuptake Inhibitors (SSRIs) combined with Cognitive Behavioral Therapy (CBT). Dermatologists can play a crucial role in identifying and managing BDD by screening patients with chronic dermatological conditions and aesthetic concerns. Collaboration with mental health professionals is essential for comprehensive care. Increased vigilance among dermatologists regarding BDD can lead to timely diagnosis, intervention, and can improve patients’ quality of life. In conclusion, the high prevalence of BDD in dermatological settings highlights the need for multidisciplinary approach to improve patient outcomes.
